| Autor: |
Namakin, Kosar, Moghaddam, Meysam Hassani, Sadeghzadeh, Sara, Mehranpour, Maryam, Vakili, Kimia, Fathi, Mobina, Golshan, Ahmadreza, Bayat, Amir-Hossein, Tajik, Amir-Hossein, Eskandari, Neda, Mohammadzadeh, Ibrahim, Benisi, Soheila Zamanlui, Aliaghaei, Abbas, Abdollahifar, Mohammad-Amin |
| Předmět: |
|
| Zdroj: |
Metabolic Brain Disease; Jun2023, Vol. 38 Issue 5, p1555-1572, 18p |
| Abstrakt: |
Irritable bowel syndrome (IBS) is related to a problem in the gut-brain axis. This experimental research aimed to shed light on the potential therapeutic application of elderberry (EB), which can work on the axis and get better the IBS symptoms. There were three groups (36 Sprague-Dawley rats) in this experiment, including control, IBS, and IBS with EB diet (IBS + EB). Making use of intracolonic instillation of 1 ml of 4% acetic acid for 30 s, IBS was induced. 7 days later, the EB extract (2%) was added to the diets of all animals for 8 weeks. Some histological, behavioral, and stereological techniques were used to detect the effects of EB on the gut and brain tissues. The findings showed that the EB diet improved locomotion and decreased anxiety-like behavior in the rat models of IBS. Moreover, the diet dropped the expression of TNF-α and increased mucosal layer thickness and the number of goblet and mast cells in colon tissue samples. In the hippocampal samples, administration of EB prevented astrogliosis and astrocyte reactivity. Although hippocampal and cortical neurons decreased markedly in the IBS group, EB prevented the drop in the number of neurons. Although lots of research is needed to elucidate the effectiveness of EB in IBS and its exact molecular mechanism, the result of this study showed that EB as an antioxidant and immune-modulatory agent could be a promising research target to prevent the impairment in the gut-brain axis, and could ameliorative classic IBS symptoms. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Full text from SpringerLink